Antibodies protect mice against challenge with tick-borne encephalitis virus (TBEV)-infected macrophages
about
The role of viral persistence in flavivirus biologyVaccine protection against Zika virus from BrazilProtective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeysMolecular mechanisms of antibody-mediated neutralisation of flavivirus infectionProspects for a Zika Virus Vaccine.Contributions of humoral and cellular immunity to vaccine-induced protection in humans.Chikungunya virus and prospects for a vaccine.Low antibody titers 5 years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccineesCorrelates of protection induced by vaccination.Plant-produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice.Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus.Aluminum hydroxide influences not only the extent but also the fine specificity and functional activity of antibody responses to tick-borne encephalitis virus in mice.Zika Virus Vaccine Development.Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge.Durability and correlates of vaccine protection against Zika virus in rhesus monkeys.Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic.Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone.A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in Mice
P2860
Q22809893-60207FC5-38CB-40AF-9576-6F1A5B79BEE1Q25165129-6EF63CAC-5AC8-4FA2-9156-086F2EE94F3DQ26248722-B103BD5A-B93E-49E1-A07B-6747014CED0AQ27488337-8354BEAD-4070-4F0D-89B6-6ECEC1F1B9C5Q30235612-2088466F-6C7E-4E88-8950-03DD0D6CCC94Q35615024-E1C32AD1-2BE7-42AA-9C10-6C73DC2B01E0Q36582816-ABD96F20-6EB0-47FF-87C9-F3A2392E2870Q37130999-478EA192-E783-49F8-BA80-2658EAF4C3BFQ37750121-9C7E3311-CAA0-4F77-939F-2CA68F3E27E8Q38157816-9D5640B9-F184-4EF1-8506-5701E898B37FQ38158247-BE3DB4D1-9FEC-494B-B13E-C653099A947FQ42272103-1ABCF8F6-3A23-4EF2-A5DD-C2865F9BB5C3Q47006432-69FD3143-0140-499E-AE8A-588F560DCA22Q47263584-C2CAE5EB-4EE9-46D9-9051-7A1B97B00B5CQ47315490-1E2E037A-798A-4EAA-AFE5-66920EBB741DQ47570091-C2709945-5255-48D0-BFEC-3BE85E55F70AQ50223468-6E0B708F-FD51-4855-9CCB-4581454FC0FCQ51336614-64989B52-1651-4C61-910F-497EF434DEFDQ58602667-C693F58D-8B09-406D-98FB-28ED57DB327A
P2860
Antibodies protect mice against challenge with tick-borne encephalitis virus (TBEV)-infected macrophages
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Antibodies protect mice agains ...... us (TBEV)-infected macrophages
@ast
Antibodies protect mice agains ...... us (TBEV)-infected macrophages
@en
Antibodies protect mice agains ...... us (TBEV)-infected macrophages
@nl
type
label
Antibodies protect mice agains ...... us (TBEV)-infected macrophages
@ast
Antibodies protect mice agains ...... us (TBEV)-infected macrophages
@en
Antibodies protect mice agains ...... us (TBEV)-infected macrophages
@nl
prefLabel
Antibodies protect mice agains ...... us (TBEV)-infected macrophages
@ast
Antibodies protect mice agains ...... us (TBEV)-infected macrophages
@en
Antibodies protect mice agains ...... us (TBEV)-infected macrophages
@nl
P2093
P3181
P1476
Antibodies protect mice agains ...... us (TBEV)-infected macrophages
@en
P2093
P304
P3181
P356
10.1046/J.1365-2249.1997.4311446.X
P577
1997-12-01T00:00:00Z